Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment.
Overview
- Department of Medical Research Center, Shaoxing People’s Hospital, School of Medicine, ShaoXing University, Shaoxing, 312000 China
- Department of Neurology, Shaoxing People’s Hospital, Shaoxing, 312000 China
- Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058 China
- National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, 310058 China
- School of Medicine, ShaoXing University, Shaoxing, 312000 China
- Department of Blood Transfusion, Shaoxing People’s Hospital (Shaoxing Hospital, Zhejiang University School of Medicine), Shaoxing, 312000 China
- Department of Traditional Chinese Medicine, Shaoxing People’s Hospital, Zhejiang University Shaoxing Hospital, Shaoxing, China
- Department of Neurosurgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310024 China
- Bioengineering College of Chongqing University, Chongqing, 400030 China
- State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Pharmaceutical Co. Ltd., 699-18 Xuan Wi Avemue, Nanjing, Jiangsu 210042 China
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
The paper links to its data, not to its authors' code: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE108476, at NCBI GEO; found in the text, “Target prediction of GBM”
Data availability statement
The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- it says that the data are available on request
Read it in the paper: doi.org/10.1186/s12967-026-08385-7.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 11 authors, 4 keywords, 20 MeSH terms, 2 funders, 76 references.
Cite
This paper
Cheng, K.-w., Zhou, S.-j., Zeng, J., Zhang, Y.-r., Jin, B.-q., Wang, P., He, L.-y., Qi, X.-c., Liu, X.-d., Yu, L.-s., & Zhang, Y.-x. (2026). Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment. Journal of translational medicine, 24(1), 1029. https://
BibTeX
@article{cheng2026dihydr
author = {Cheng, Kai-wen and Zhou, Shao-jun and Zeng, Jie and Zhang, Yang-rui and Jin, Bing-qian and Wang, Ping and He, Ling-yan and Qi, Xu-chen and Liu, Xu-dong and Yu, Lu-shan and Zhang, Yan-xing},
title = {{Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment}},
journal = {Journal of translational medicine},
year = {2026},
month = jun,
volume = {24},
number = {1},
pages = {1029},
publisher = {BMC},
issn = {1479-5876},
doi = {10.1186/
url = {https://
pmid = {42277880},
pmcid = {PMC13465433}
}
RIS
TY - JOUR
AU - Cheng, Kai-wen
AU - Zhou, Shao-jun
AU - Zeng, Jie
AU - Zhang, Yang-rui
AU - Jin, Bing-qian
AU - Wang, Ping
AU - He, Ling-yan
AU - Qi, Xu-chen
AU - Liu, Xu-dong
AU - Yu, Lu-shan
AU - Zhang, Yan-xing
TI - Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment
T2 - Journal of translational medicine
J2 - J Transl Med
PY - 2026
DA - 2026/
VL - 24
IS - 1
SP - 1029
SN - 1479-5876
PB - BMC
DO - 10.1186/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1186/
"type": "article-journal",
"title": "Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment",
"container-title": "Journal of translational medicine",
"author": [
{
"family": "Cheng",
"given": "Kai-wen"
},
{
"family": "Zhou",
"given": "Shao-jun"
},
{
"family": "Zeng",
"given": "Jie"
},
{
"family": "Zhang",
"given": "Yang-rui"
},
{
"family": "Jin",
"given": "Bing-qian"
},
{
"family": "Wang",
"given": "Ping"
},
{
"family": "He",
"given": "Ling-yan"
},
{
"family": "Qi",
"given": "Xu-chen"
},
{
"family": "Liu",
"given": "Xu-dong"
},
{
"family": "Yu",
"given": "Lu-shan"
},
{
"family": "Zhang",
"given": "Yan-xing"
}
],
"container-title-short":
"volume": "24",
"issue": "1",
"page": "1029",
"DOI": "10.1186/
"PMID": "42277880",
"PMCID": "PMC13465433",
"ISSN": "1479-5876",
"publisher": "BMC",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
11
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.3390/genes17050511
- Machine Learning-Based Classification of Gliomas and Tumor Grades with SHAP-Guided Feature Interpretation.Journal: GenesIn common: NCBI GEO GSE108476, other condition, cellular / molecular, 1 reference
- [2] doi:10.3390/ijms27146196
- Investigation of the Potential Neuroprotective Mechanisms of &
lt;i& gt;Acalypha indica& lt;/ i& gt; Against Alzheimer's Disease by Integrated Bioinformatics Analysis. Journal: International journal of molecular sciencesIn common: cellular / molecular, 5 references - [3] doi:10.3390/metabo16080541
- Spatial Metabolomics and Single-Cell Virtual Knockout Screening Reveal Solanesol Improves Parkinson's Disease-like Pathology Based on Lipid Inflammation Mechanism.Journal: MetabolitesIn common: cellular / molecular, 4 references
- [4] doi:10.21203/rs.3.rs-9060414/v1 [code]
- Cross-Species Aging Knowledge Integration into Agentic AI Platform Uncovers Conserved MechanismsJournal: Research Square (preprint)In common: cellular / molecular, 3 references
- [5] doi:10.1038/s41586-026-10451-5
- Androgen loss accelerates brain tumour growth via HPA axis activation.Journal: NatureIn common: other condition, mouse, cellular / molecular, 2 references
- [6] doi:10.3389/fphar.2026.1797067
- Network-driven prioritization and functional phenotyping nominate TTC23 as a biomarker-informed target in chlorpromazine repurposing for glioblastoma.Journal: Frontiers in pharmacologyIn common: other condition, 3 references
- [7] doi:10.1038/s41467-026-76587-0 [code]
- Uncovering the signaling networks of disseminated glioblastoma cells in vivo with INSIGHT.Journal: Nature communicationsIn common: other condition, mouse, cellular / molecular, 2 references
- [8] doi:10.1093/neuonc/noag080
- Laser interstitial thermal therapy enhances bidirectional blood-brain barrier permeability in glioblastoma.Journal: Neuro-oncologyIn common: other condition, mouse, 2 references
- [9] doi:10.1101/gr.281113.125 [code]
- Single-nucleus multiomic profiling of the aging mouse substantia nigra reveals conserved gene alterations linked to Parkinson's disease.Journal: Genome researchIn common: mouse, cellular / molecular, 2 references
- [10] doi:10.1021/acsomega.5c11807
- Repurposing &
lt;i& gt;T‑614& lt;/ i& gt; for Gout: An In Silico Framework Integrating Network Pharmacology, Mendelian Randomization, and Single-Cell and Molecular Dynamics Analyses. Journal: ACS omegaIn common: cellular / molecular, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.